XML 20 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 12 $ 788,697 $ (697,578) $ 91,131
Balance, shares at Dec. 31, 2023 114,963,193      
Stockholders' Equity (Deficit)        
Issuance of common stock upon exercise of stock options   4,870   4,870
Issuance of common stock upon exercise of stock options, shares 1,025,384      
Issuance of common stock upon vesting of restricted stock units (in shares) 532,717      
Issuance of common stock and pre-funded warrants upon private placement, net of issuance costs $ 3 316,350   316,353
Issuance of common stock and pre-funded warrants upon private placement, net of issuance costs, shares 32,413,560      
Issuance of common stock in connection with conversion of Convertible Notes   52,499   52,499
Issuance of common stock in connection with conversion of Convertible Notes, shares 5,769,232      
Stock-based compensation expense   7,978   7,978
Net Income (Loss)     (64,848) (64,848)
Balance at Mar. 31, 2024 $ 15 1,170,394 (762,426) 407,983
Balance, shares at Mar. 31, 2024 154,704,086      
Balance at Dec. 31, 2024 $ 16 1,206,412 (891,084) 315,344
Balance, shares at Dec. 31, 2024 157,749,490      
Stockholders' Equity (Deficit)        
Issuance of common stock upon exercise of stock options   4,183   4,183
Issuance of common stock upon exercise of stock options, shares 880,115      
Issuance of common stock upon vesting of restricted stock units (in shares) 632,419      
Stock-based compensation expense   10,456   10,456
Net Income (Loss)     (64,053) (64,053)
Balance at Mar. 31, 2025 $ 16 $ 1,221,051 $ (955,137) $ 265,930
Balance, shares at Mar. 31, 2025 159,262,024